Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study
Description
BACKGROUND: At least 5-10% of subjects surviving COVID-19 develop the post-COVID-19 condition (PCC) or "Long COVID". The clinical presentation of PCC is heterogeneous, its pathogenesis is being deciphered, and objective, validated biomarkers are
